Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19
Clinical trial NCT04351152 · UNKNOWN
Trial details
- NCT number
- NCT04351152
- Sponsor
- Humanigen, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2021-03-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.